Literature DB >> 23095085

Emergence of a multidrug-resistant Haemophilus influenzae strain causing chronic pneumonia in a patient with common variable immunodeficiency.

Yvonne Pfeifer1, Ines Meisinger, Klaus Brechtel, Sabine Gröbner.   

Abstract

We report the emergence of a multidrug-resistant Haemophilus influenzae strain in a patient with common variable immunodeficiency suffering from recurrent bronchopneumonia caused by H. influenzae. After the patient had received several antibiotic therapies, a strain was isolated showing resistance to ampicillin, ampicillin/sulbactam, cefazolin, cefuroxime, ciprofloxacin, and clarithromycin. Polymerase chain reaction analyses and sequencing revealed the presence of the beta-lactamase gene bla(TEM-1), two mutations (A502T and R517H) in the ftsI gene encoding the transpeptidase region of the penicillin-binding protein 3, and one mutation in the ribosomal protein gene L4 (G65D) conferring resistance to beta-lactams and macrolides, respectively. Additionally, the plasmid-encoded aac(6')-Ib-cr gene mediating slightly reduced susceptibility to quinolones and two mutations in the DNA gyrase gene gyrA and one mutation in the topoisomerase IV gene parC were identified leading to a high-level fluoroquinolone-resistant phenotype. In conclusion, the treatment of H. influenzae infections accompanied by high bacterial loads such as bronchopneumonia can be complicated by the selection of multidrug-resistant strains. Moreover, the emergence of aac(6')-Ib-cr in H. influenzae causing low fluoroquinolone resistance levels might have contributed to the selection of DNA gyrase and topoisomerase IV mutants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095085     DOI: 10.1089/mdr.2012.0060

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  Emergence of extensively drug-resistant Haemophilus parainfluenzae in Switzerland.

Authors:  Regula Tinguely; Salome N Seiffert; Hansjakob Furrer; Vincent Perreten; Sara Droz; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

2.  Case Report: Whole-Genome Sequencing of Serially Collected Haemophilus influenzae From a Patient With Common Variable Immunodeficiency Reveals Within-Host Evolution of Resistance to Trimethoprim-Sulfamethoxazole and Azithromycin After Prolonged Treatment With These Antibiotics.

Authors:  Paul Christoffer Lindemann; Haima Mylvaganam; Oddvar Oppegaard; Inger Lill Anthonisen; Nermin Zecic; Dagfinn Skaare
Journal:  Front Cell Infect Microbiol       Date:  2022-06-01       Impact factor: 6.073

3.  Structure-based function analysis of putative conserved proteins with isomerase activity from Haemophilus influenzae.

Authors:  Mohd Shahbaaz; Faizan Ahmad; Md Imtaiyaz Hassan
Journal:  3 Biotech       Date:  2014-12-28       Impact factor: 2.406

4.  Extensively drug-resistant Haemophilus influenzae - emergence, epidemiology, risk factors, and regimen.

Authors:  Pei-Yi Su; Ay-Huey Huang; Chung-Hsu Lai; Hsiu-Fang Lin; Tsun-Mei Lin; Cheng-Hsun Ho
Journal:  BMC Microbiol       Date:  2020-04-28       Impact factor: 3.605

5.  Role of Horizontal Gene Transfer in the Development of Multidrug Resistance in Haemophilus influenzae.

Authors:  Kristin Hegstad; Haima Mylvaganam; Jessin Janice; Ellen Josefsen; Audun Sivertsen; Dagfinn Skaare
Journal:  mSphere       Date:  2020-01-29       Impact factor: 4.389

6.  Characterization and Fitness Cost of Tn7100, a Novel Integrative and Conjugative Element Conferring Multidrug Resistance in Haemophilus influenzae.

Authors:  Helene Johannessen; Inger Lill Anthonisen; Nermin Zecic; Kristin Hegstad; Trond Egil Ranheim; Dagfinn Skaare
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

7.  Changes in the prevalence and biofilm formation of Haemophilus influenzae and Haemophilus parainfluenzae from the respiratory microbiota of patients with sarcoidosis.

Authors:  Urszula Kosikowska; Paweł Rybojad; Dagmara Stępień-Pyśniak; Anna Żbikowska; Anna Malm
Journal:  BMC Infect Dis       Date:  2016-08-26       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.